Advertisement
UK markets close in 2 hours 41 minutes
  • FTSE 100

    8,089.65
    +49.27 (+0.61%)
     
  • FTSE 250

    19,703.36
    -16.01 (-0.08%)
     
  • AIM

    755.28
    +0.59 (+0.08%)
     
  • GBP/EUR

    1.1666
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2478
    +0.0016 (+0.13%)
     
  • Bitcoin GBP

    51,069.79
    -2,197.27 (-4.13%)
     
  • CMC Crypto 200

    1,365.47
    -17.10 (-1.24%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.08
    +0.27 (+0.33%)
     
  • GOLD FUTURES

    2,337.20
    -1.20 (-0.05%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,954.54
    -134.16 (-0.74%)
     
  • CAC 40

    8,005.36
    -86.50 (-1.07%)
     

How Analysts Rated Jazz Pharmaceuticals in December

In December 2017, Jazz Pharmaceuticals (JAZZ) submitted a New Drug Application (or NDA) to the FDA for the approval of JZP-110.